179 related articles for article (PubMed ID: 26208856)
1. Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer.
Melling N; Muth J; Simon R; Bokemeyer C; Terracciano L; Sauter G; Izbicki JR; Marx AH
Diagn Pathol; 2015 Jul; 10():125. PubMed ID: 26208856
[TBL] [Abstract][Full Text] [Related]
2. Expression of phospho-mTOR kinase is abundant in colorectal cancer and associated with left-sided tumor localization.
Melling N; Simon R; Izbicki JR; Terracciano LM; Bokemeyer C; Sauter G; Marx AH
Int J Clin Exp Pathol; 2015; 8(6):7009-15. PubMed ID: 26261591
[TBL] [Abstract][Full Text] [Related]
3. High expression of cell division cycle 7 protein correlates with poor prognosis in patients with diffuse large B-cell lymphoma.
Hou Y; Wang HQ; Ba Y
Med Oncol; 2012 Dec; 29(5):3498-503. PubMed ID: 22528513
[TBL] [Abstract][Full Text] [Related]
4. Loss of H2Bub1 Expression is Linked to Poor Prognosis in Nodal Negative Colorectal Cancers.
Melling N; Grimm N; Simon R; Stahl P; Bokemeyer C; Terracciano L; Sauter G; Izbicki JR; Marx AH
Pathol Oncol Res; 2016 Jan; 22(1):95-102. PubMed ID: 26347467
[TBL] [Abstract][Full Text] [Related]
5. High Ki67 expression is an independent good prognostic marker in colorectal cancer.
Melling N; Kowitz CM; Simon R; Bokemeyer C; Terracciano L; Sauter G; Izbicki JR; Marx AH
J Clin Pathol; 2016 Mar; 69(3):209-14. PubMed ID: 26281861
[TBL] [Abstract][Full Text] [Related]
6. Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents.
Cheng AN; Jiang SS; Fan CC; Lo YK; Kuo CY; Chen CH; Liu YL; Lee CC; Chen WS; Huang TS; Wang TY; Lee AY
Cancer Lett; 2013 Sep; 337(2):218-25. PubMed ID: 23684929
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer.
Faggad A; Kasajima A; Weichert W; Stenzinger A; Elwali NE; Dietel M; Denkert C
Histopathology; 2012 Oct; 61(4):552-61. PubMed ID: 22716222
[TBL] [Abstract][Full Text] [Related]
8. Lemur tyrosine kinase-3 is a significant prognostic marker for patients with colorectal cancer.
Shi H; Li Q; Ji M; Wu J; Li Z; Zheng X; Xu B; Chen L; Li X; Lu C; Tan Y; Wu C; Jiang J
Int J Clin Exp Pathol; 2014; 7(3):1101-7. PubMed ID: 24695631
[TBL] [Abstract][Full Text] [Related]
9. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.
Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic significance of TRAP1 expression in colorectal cancer: a large scale study of human colorectal adenocarcinoma tissues.
Pak MG; Koh HJ; Roh MS
Diagn Pathol; 2017 Jan; 12(1):6. PubMed ID: 28088229
[TBL] [Abstract][Full Text] [Related]
11. Gremlin1 expression associates with serrated pathway and favourable prognosis in colorectal cancer.
Pelli A; Väyrynen JP; Klintrup K; Mäkelä J; Mäkinen MJ; Tuomisto A; Karttunen TJ
Histopathology; 2016 Nov; 69(5):831-838. PubMed ID: 27257976
[TBL] [Abstract][Full Text] [Related]
12. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of neurone glial-related cell adhesion molecule is an independent predictor of poor prognosis in advanced colorectal cancer.
Chan JY; Ong CW; Salto-Tellez M
Cancer Sci; 2011 Oct; 102(10):1855-61. PubMed ID: 21718388
[TBL] [Abstract][Full Text] [Related]
14. Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value.
Cui R; Shi XY
Int J Clin Exp Pathol; 2015; 8(9):11393-9. PubMed ID: 26617865
[TBL] [Abstract][Full Text] [Related]
15. Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.
Bae JM; Lee TH; Cho NY; Kim TY; Kang GH
World J Gastroenterol; 2015 Feb; 21(5):1457-67. PubMed ID: 25663765
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients.
Yu MH; Luo Y; Qin SL; Zhong M
Int J Clin Exp Pathol; 2015; 8(6):6974-80. PubMed ID: 26261586
[TBL] [Abstract][Full Text] [Related]
17. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer.
Kim JH; Rhee YY; Bae JM; Cho NY; Kang GH
Am J Surg Pathol; 2013 Oct; 37(10):1532-41. PubMed ID: 24025523
[TBL] [Abstract][Full Text] [Related]
18. Cell division cycle-associated protein 1 overexpression is essential for the malignant potential of colorectal cancers.
Kobayashi Y; Takano A; Miyagi Y; Tsuchiya E; Sonoda H; Shimizu T; Okabe H; Tani T; Fujiyama Y; Daigo Y
Int J Oncol; 2014 Jan; 44(1):69-77. PubMed ID: 24247253
[TBL] [Abstract][Full Text] [Related]
19. High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer.
Yan X; Yan L; Zhou J; Liu S; Shan Z; Jiang C; Tian Y; Jin Z
Int J Clin Exp Pathol; 2014; 7(12):8715-23. PubMed ID: 25674237
[TBL] [Abstract][Full Text] [Related]
20. Annexin A10 expression in colorectal cancers with emphasis on the serrated neoplasia pathway.
Bae JM; Kim JH; Rhee YY; Cho NY; Kim TY; Kang GH
World J Gastroenterol; 2015 Sep; 21(33):9749-57. PubMed ID: 26361422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]